This type of disorder shares certain clinical characteristics, which makes it difficult its differentiated diagnosis. The common findings include: cutaneous synovitis, pleurisies, Myocarditis, endocarditis, pericarditis, peritonitis, vasculitis, myositis, eruptions and alterations of connective tissue and kidneys. Laboratory exams frequently reveal hemolytic anemia, plateletpenia, leucopenia, excess or deficit of immunoglobulins, presence of antinuclear antibodies, rheumatoid factor, crioglobulins, elevation of muscular enzymes and alterations of seric complement (C3, c4, ch50).
Within the group called autoimmune diseases, are: rheumatoid arthritis, systemic Erithematosus lupus, scleroderma, polymyositis, dermatomyositis, Sjogren syndrome, rhabdomyolisis, polyarteritis nodosa, microscopic polyangeitis, rheumatic polymialgia, giant cell arteritis, disease of Still, Wegener's granulomatosis, cryoglobulinemia, Henoch-Schonlein purpura, Behcet's syndrome, ankylosans spondylitis, hemolytic autoimmune anemia, autoimmune hepatopathy and others.
Another common denominator in this group of diseases is the conventionally used treatment, which consists of drugs with immunosuppressive effects (immunological system depressing drugs) such as:
• Cyclosporine and tacrolimo (which are nephrotoxic, hypertensive, neuro-toxic, etc.
• Prednisone, methylprednisolone and other suprarenal corticosteroids (associated to gastric ulcers, diabetes, osteoporosis, infections, hypertension and others)
- Azatriopine, cyclophosfamide, which are nonselective cytotoxic agents (their active principles destroy the DNA of ill and healthy cells without distinction);
- Hydroxichloroquine, Methotrexate (associated with damages at retinal and hepatic level respectively).
Within the group of adaptogens used in Systemic Medicine for the treatment of this type of diseases, the emphasis is in a group of superior plants whose active principles are well-known and have verified immunemodulating effects (modulation of immunological activity, without suppressing it), among them: Astrágalus membranáceus, Ganoderma lucidum, Morinda citrifolia and Sutherlandia frutescens; which act in a synergic way, each boosting the other (herbaria synergy mechanism) reason why its use in combination obtains greater results than the algebraic sum of each one of them.
Immunomodulation and not immunosuppressive, is the correct route for the treatment of patients with autoimmune diseases, since the regularization of immunological system's activity entails the remission of the problem, that is to say, corrects the cause of the disease, unlike conventional treatments that treat the symptom and have indirect severe effects, that in many occasions endanger the patient's life.
The sequence for the manifestation of an incurable disease is: 1) aggressor agent, 2) weakening of the biological Intelligence; and 3)"incurable".
In view of this logic, Systemic Medicine postulates that to obtain the clinical remission of the patient with "incurables" diseases (including autoimmune diseases), its necessary:
1-Re-establish the biological Intelligence with adaptogens that stimulate the biological Intelligence; and
2-Eliminate causal agents (biological, physical, chemical and emotional).
With the Systemic Medicine approach the total or partial reestablishment of 80% of this group of patients can be obtained, without the indirect effects that can be produced by conventional treatments.
